Laura Wharam thought she had appendicitis but her breast cancer had returned and metastasized, spreading to her liver, bones, ...

More widespread use of mammograms, along with the implementation of targeted hormone therapies more than 40 years ago, has ...

Higher TIL levels predict better survival in early ERBB2-positive breast cancer, supporting treatment de-escalation for select patients.

Zongertinib, an investigational treatment for HER2-mutant advanced NSCLC, has received FDA priority review, showing positive ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.